Why did IPX.AX stock fall sharply on 13 Mar 2026?

The drop reflected heavy volume, a gap down in related ADR listings, and short‑term profit taking. Market flows and institutional rebalancing amplified selling pressure ahead of the next earnings date on 17 Mar 2026.

What is Meyka AI's view on IPX.AX stock?

Meyka AI rates IPX.AX **60.01/100** (Grade B, HOLD). The model highlights upside from commercialisation but flags execution risk and stretched valuation metrics.

What are the key financial metrics for IperionX (IPX.AX)?

Key metrics: price **A$5.26**, EPS **-0.19**, PE **-32.21**, PB **15.02**, market cap about **A$2.07B**, current ratio **6.99** and shares outstanding **337,595,858**.

What price targets and outlook exist for IPX.AX stock?

Meyka AI's forecast model projects monthly **A$5.81**, quarterly **A$6.03**, and 12‑month **A$8.95**, implying about **70.06%** upside to the 12‑month figure from today's close. Forecasts are projections and not guarantees.

AU Stocks

IPX.AX falls 26.33% to A$5.26 on 13 Mar 2026: drivers and outlook

ByHuzaifa Zahoor March 13, 2026March 13, 2026

IPX.AX stock dropped 26.33% to A$5.26 at the close on 13 Mar 2026, making IperionX Limited one of the top losers on the ASX today. Trading volume surged to 2,148,094 shares versus an average of 1,048,398, signalling heavy selling pressure after the stock opened at A$5.89 and came from a prior close of A$7.14. The move cut the stock well below its 50‑day average of A$6.68 and left short‑term momentum indicators mixed. We examine valuation, catalysts, and the near‑term outlook for IperionX Limited (IPX.AX) on the ASX